Home > Healthcare > Medical Devices > Surgical Devices > Heart Closure Devices Market

Heart Closure Devices Market Share

Report ID: GMI6140
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Heart Closure Devices Market Share

Some of the major companies operating in the heart closure devices market are:

Abbott Laboratories
AtriCure Inc
Biosense Webster Inc
Boston Scientific Corporation,
Cardia, Inc.

Major companies are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company growth.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of heart closure devices was reached USD 2.2 billion in 2022 and is estimated to be worth more than USD 6.6 billion by 2032, due to the growing prevalence of cardiovascular diseases and higher adoption of minimally invasive procedures.

The left atrial appendage (LAA) closure devices product segment is projected to generate more than USD 2.9 billion by 2032, owing to several advantages associated with these devices in the heart closure treatment procedures.

U.S. market is estimated to expand at a notable pace and amass more than USD 2.7 billion by 2032 driven by the strong presence of major industry players, scaling demand for heart closure procedures, and the high prevalence of cardiovascular conditions.

Some of the top companies operating in the industry are Abbott Laboratories, AtriCure Inc., Biosense Webster, Inc., Boston Scientific Corporation, and Cardia, Inc.